Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 03/06/2020.
Spécialités Pharmaceutiques importées :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | BLISSEL | ESTRIOL | 50µg/gr | GEL VAGINAL | T/10gr+10 canules | ITALFARMACO ESPANGE | I | N | 12/03/2020 |
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | LOTEMAX | LOTEPREDNOL | 0.5% | GEL OPHTALMIQUE | FL /10ml | BAUSCH AND LOMB | E | N | 29/09/2019 |
2 | RELVAR ELLIPTA | FUROATE DE FLUTICASONE/VILANTEROL | 92/22µg | PDRE PR INHALATION BUCCALE | B/1 INH DE 30 DOSES | GALAXO GROUP LTD | E | V | 30/09/2019 |
3 | RELVAR ELLIPTA | FUROATE DE FLUTICASONE/VILANTEROL | 184/22µg | PDRE PR INHALATION BUCCALE | B/1 INH DE 30 DOSES | GALAXO GROUP LTD | E | V | 30/09/2019 |
4 | STELARA | USTEKINUMAB | 45 mg/0.5ml | SOL INJ | B/1FL/0.5ml | Janssen-Cilag International N.V | E | N | 01/10/2019 |
5 | STELARA | USTEKINUMAB | 45 mg/0.5ml | SOL INJ | B/1seringue pré-remplie/0.5ml | Janssen-Cilag International N.V | E | N | 01/10/2019 |
6 | STELARA | USTEKINUMAB | 130mg/26ml | SOL INJ PR PERF | B/1FL/30ML | Janssen-Cilag International N.V | E | N | 01/10/2019 |
7 | STELARA | USTEKINUMAB | 90mg/ml | SOL INJ | B/1Seringue pré-remplie/1ml | Janssen-Cilag International N.V | E | N | 01/10/2019 |
8 | PMS-RISEDRONATE | RISEDRONATE | 35 mg | COMP PEL | B/4 | PHARMASCIENCE INC CANADA | E | N | 02/10/2019 |
9 | PROLUTEX | PROGESTERONE | 25mg | SOL INJ | B/7Flacons | IBSA Institut Biochimique SA | E | N | 02/10/2019 |
10 | AKYNZEO | NETUPITANT+PALONOSETRON | 300mg/ 0.5mg | GELLULE | B/1 | HELSINN BIREX Pharmaceuticals Ltd | E | N | 07/10/2019 |
11 | TARGINACT | OXYCODONE+NALOXONE | 40mg/20mg | COMP | B/56 | Napp Pharmaceuticals Limited | V | N | 08/10/2019 |
12 | TARGINACT | OXYCODONE+NALOXONE | 20mg/10mg | COMP | B/56 | Napp Pharmaceuticals Limited | V | N | 08/10/2019 |
13 | TARGINACT | OXYCODONE+NALOXONE | 10mg/5mg | COMP | B/56 | Napp Pharmaceuticals Limited | V | N | 08/10/2019 |
14 | ALDARA | IMIQUIMOD | 5% | CREME DERMIQUE | B/12 Sachets Unidoses/250 mg | MEDA AB | E | N | 09/10/2019 |
15 | RANEXA | RANOLAZINE | 500 mg | COMP | B/60 | Menarini International Operation Luxembourg S.A | E | N | 23/10/2019 |
16 | RANEXA | RANOLAZINE | 750 mg | COMP | B/60 | Menarini International Operation Luxembourg S.A | E | N | 23/10/2019 |
17 | MYDRANE | TROPICAMIDE+ CHLORHYDRATE DE PHENYLEPHRINE+ CHLORHYDRATE DE | 0.2mg/ml+ 3.1mg/ml+ 10mg/ml | AMPOULE | B/20 Ampoules de 1 ml + 20 aiguilles | THEA | I | N | 24/10/2019 |
18 | HUMIRA | ADALIMUMAB | 40 mg | SERINGUE | B/2 seringues/0.4 ml | ABBVIE DEUTSCHLAND Gmbh and Co.KG | E | N | 29/10/2019 |
19 | LIPANTHYL | FENOFIBRATE | 145 mg | COMP PEL | B/30 | MYLAN MEDICAL SAS | E | N | 29/10/2019 |
20 | SIMPONI | GOLIMUMAB | 100 mg | SOL INJ | B/1 Stylo Pré-rempli/1ml | JANSSEN BIOLOGICS B.V | V | N | 12/11/2019 |
21 | INLYTA | AXITINIB | 5 mg | COMP PEL | B/28 | PFIZER AG | V | N | 20/11/2019 |
22 | INLYTA | AXITINIB | 5 mg | COMP PEL | B/56 | PFIZER AG | V | N | 20/11/2019 |
23 | INLYTA | AXITINIB | 1 mg | COMP PEL | B/56 | PFIZER AG | V | N | 20/11/2019 |
24 | INLYTA | AXITINIB | 1 mg | COMP PEL | B/28 | PFIZER AG | V | N | 20/11/2019 |
25 | TOT'HEMA | CUIVRE+MANGANESE+FER | 0.7mg/1.33mg/50mg | SOL BUV | B/20AMP/10ml | INNOTECH INTERNATIONAL | E | N | 26/11/2019 |
26 | DEXAFREE | DEXAMETHASONE | 1 mg/ml | COLLYRE MONODOSE | B/30 unidoses/0.4 ml | THEA | E | N | 28/11/2019 |
27 | PRILIGY | DAPOXETINE | 30 mg | COMP PEL | B/3 | MENARINI Ind.Farmaceutiche Riunite SRL | C | N | 18/12/2019 |
28 | PRILIGY | DAPOXETINE | 60 mg | COMP PEL | B/3 | MENARINI Ind.Farmaceutiche Riunite SRL | C | N | 18/12/2019 |
29 | MIRVASO | BRIMONIDINE | 3MG/GR | GEL DERMIQUE | Tube/30gr | GALDERMA INTERNATIONAL | C | N | 27/12/2019 |
30 | EYLEA | AFLIBERCEPT | 40 mg/ml | SOL INJ | FL/ 100 ml | BAYER AG Leverkusen | N | 30/12/2019 | |
31 | ALLERGODIL | AZELASTINE | 0.05% | COLLYRE | FL/6ML | MEDA PHARMA | E | N | 21/01/2020 |
32 | SUPRANE | DESFLURANE | 100% | LIQUIDE VOLATIL | B/ 6 FL/240ML | BAXTER HEALTHCARE | V | N | 24/02/2020 |
33 | SEVOFLURANE USP | SEVOFLURANE | 100% | LIQUIDE VOLATIL | B/ 6 FL/250ML | BAXTER HEALTHCARE | V | N | 24/02/2020 |
34 | SEVOFLURANE USP | SEVOFLURANE | 100% | LIQUIDE PR INHA | B/1FL /250ML | PIRAMAL CRITICAL CARE INC | V | N | 24/02/2020 |
35 | BUTRANS | BUPRENORPHINE | 5ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
36 | BUTRANS | BUPRENORPHINE | 10ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
37 | BUTRANS | BUPRENORPHINE | 20ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
38 | OXYCONTIN | OXYCODONE | 10mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
39 | OXYCONTIN | OXYCODONE | 15mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
40 | OXYCONTIN | OXYCODONE | 20mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
41 | OXYCONTIN | OXYCODONE | 30mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
42 | OXYCONTIN | OXYCODONE | 40mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
43 | RAPAMUNE | SIROLIMUS | 1mg | cp enrobé | B/30 | PFIZER Europe MA EEIG | E | N | 13/04/2020 |
44 | CANCIDAS | CASPOFUNGINE | 50mg | Poudre pour prep injectable | B/1 | MSD | E | N | 17/04/2020 |
45 | CANCIDAS | CASPOFUNGINE | 70mg | Poudre pour prep injectable | B/1 | MSD | E | N | 17/04/2020 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | RAPIFEN | ALFENTANIL | 1 mg (0.5mg/ml) | SOL INJ | B/5/2 ML | Piramal Critical Care Limited | V | N | TRANSFERT 06/12/2019 |
2 | DARZALEX | Daratumumab | 20mg/ml | SOL INJ | B/1FL/5ML | Janssen-Cilag International N.V | N | CS 03/12/2019 | |
3 | DARZALEX | Daratumumab | 20mg/ml | SOL INJ | B/1FL/20ML | Janssen-Cilag International N.V | N | CS 03/12/2019 | |
4 | PURINETHOL | MERCAPTOPURINE | 50 MG | COMP SECABLE | FL/25 | ASPEN PHARMA | V | V | CS 03/12/2019 |
5 | TASIGNA | NILOTINIB | 150 mg | GELULE | B/112 | NOVARTIS PHARMA | V | V | CS 03/12/2019 |
6 | TASIGNA | NILOTINIB | 200 mg | GELULE | B/28 | NOVARTIS PHARMA | V | V | CS 03/12/2019 |
7 | IMBRUVICA | IBRUTINIB | 140 MG | GELULE | B/90 | Janssen-Cilag International N.V | E | V | CS 03/12/2019 |
8 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/7 | ABBVIE ltd | N | CS 03/12/2019 | |
9 | VENCLYXTO | VENETOCLAX | 50 mg | COMP PEL | B/7 | ABBVIE ltd | N | CS 03/12/2019 | |
10 | VENCLYXTO | VENETOCLAX | 10 mg | COMP PEL | B/14 | ABBVIE ltd | N | CS 03/12/2019 | |
11 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/14 | ABBVIE ltd | N | CS 03/12/2019 | |
12 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/112 | ABBVIE ltd | N | CS 03/12/2019 | |
13 | ZIAGEN | ABACAVIR | 300 mg | COMP PEL | B/60 | ViiV Healthcare BV | E | N | Transfert 04/12/2019 |
14 | VIAGRA | SILDENAFIL | 25 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 09/12/2019 |
15 | VIAGRA | SILDENAFIL | 50 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 16/12/2019 |
16 | VIAGRA | SILDENAFIL | 100 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 16/12/2019 |
17 | INVANZ | ERTAPENEM | 1 GR | PDRE PR PREP INJ | B/1F/15ML | Merck Sharp & Dohme Ltd R.U | E | N | CS 20/12/2019 |
18 | RIFOCINE | RIFAMYCINE | 250 MG | SOL INJ | B/1FL/3ML | SANOFI AVENTIS SPA | E | V | CS 20/12/2019 |
19 | PREVENAR 13 | VACCIN PNEUMOCOCCIQUE | NA | SUSP INJ | B/1seringue pré-remplie/0.5ml | PFIZER Europe MA EEIG | I | N | TRANSFERT 20/12/2019 |
20 | SOLICARE | SOLIFENACINE SUCCINATE | 5 mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 20/12/2019 |
21 | SOLICARE | SOLIFENACINE SUCCINATE | 10 mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 20/12/2019 |
22 | RILUZOLE MYLAN 50 | RILUZOLE | 50 mg | COMP PEL | B/56 | MYLAN S.A.S | E | N | 24/12/2019 |
23 | DUPHASTON | DYDROGESTERONE | 10 MG | COMP | B/10 | Abbott B.V | E | N | TRANSFERT 25/12/2019 |
24 | RHESONATIV | IMMUNOGLOBUNE HUMAINE ANTI D | 625 UI/ML | SOL INJ | B/1/2ML | OCTAPHARMA | E | V | 25/12/2019 |
25 | KETODERM 2% GEL EN SACHET | KETOCONAZOLE | 2% | GEL DERMIQUE | B/8/6 GR | EG LABO - Laboratoires Eurogenerics SAS | E | N | TRANSFERT 31/12/2019 |
26 | XOLAIR | OMALIZUMAB | 150 mg | PDRE PR SOL INJ | B/1F | NOVARTIS PHARMA AG | V | CS 06/01/2020 | |
27 | BRICANYL LP | TERBUTALINE | 5 MG | COMP LP | FL/60 | ASTRA ZENECA | E | V | CS 06/01/2020 |
28 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | CS 06/01/2020 |
29 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/60 | Bristol-Myers Squibb/Pfizr EEIG | E | N | CS 06/01/2020 |
30 | ELIQUIS | APIXABAN | 2,5MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT CS 06/01/2020 |
31 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT CS 06/01/2020 |
32 | SUXAMETHONIUM-LABESFAL | SUXAMETHONIUM | 100 MG/2ML | SOL INJ | B/100/2ML | LABESFAL | V | V | CS 06/01/2020 |
33 | DESLORATADINE GENEPHARM | DESLORATADINE | 5 MG | COMP | B/30 | GENEPHARM S.A | E | N | 15/01/2020 |
34 | DESLORATADINE GENEPHARM | DESLORATADINE | 2,5 MG | COMP | B/30 | GENEPHARM S.A | E | N | 15/01/2020 |
35 | LEVONORGESTREL MYLAN | LEVONORGESTREL | 1.5 mg | COMP | B/1 | MYLAN S.A.S | E | N | 15/01/2020 |
36 | VAXIGRIP | VACCIN ANTIGRIPPE | SUSP INJ | B/1SER/0,5 ML | SANOFI PASTEUR SA | I | V | CS 17/01/2020 | |
37 | JADENU | DEFERASIROX | 360MG | COMP PEL | B/30 | NOVARTIS PHARMA SCHWEIZ AG | V | N | 22/01/2020 |
38 | JADENU | DEFERASIROX | 180MG | COMP PEL | B/90 | NOVARTIS PHARMA | V | N | 22/01/2020 |
39 | JADENU | DEFERASIROX | 90MG | COMP PEL | B/90 | NOVARTIS PHARMA | V | N | 22/01/2020 |
40 | VESOMNI | SOLIFENACINE+ TAMSULOSINE | 6mg/0.4mg | COMP | B/30 | ASTELLAS PHARMA EUROPE B.V HOLLANDE | N | 22/01/2020 | |
41 | TOMEC | DORZOLAMIDE+ TIMOLOL | 100 mg/ 25mg | COLLYRE | FL/5 ml | ABDI IBRAHIM IIac San. ve Tic. A.S. | E | N | 22/01/2020 |
42 | OFNOL | OLOPATADINE | 0.1% | COLLYRE | FL/5 ml | ABDI IBRAHIM IIac San. ve Tic. A.S. | E | N | 04/02/2020 |
43 | ORAP | PIMOZIDE | 4 MG | COMP | B/30 | EUMEDICA PHARMACEUTICALS GmbH | E | N | TRANSFERT 04/02/2020 |
44 | LYRICA | PREGABALINE | 75 mg | GEL | B/56 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
45 | LYRICA | PREGABALINE | 75 mg | GEL | B/56 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
46 | LYRICA | PREGABALINE | 150 mg | GEL | B/14 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
47 | ALECENSA | ALECTINIB | 150 MG | GELULE | B/224 | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | N | 10/02/2020 | |
48 | NOCDURNA | DESMOPRESSINE | 50 µg | LYOPHI ORAL | B/30 | FERRING ARZNEIMITTEL GmbH | E | N | 17/02/2020 |
49 | NOCDURNA | DESMOPRESSINE | 25 µg | LYOPHI ORAL | B/30 | FERRING ARZNEIMITTEL GmbH | E | N | 17/02/2020 |
50 | TOBREX | TOBRAMYCINE | 0.3% | pommade ophtalmo | Tube/3.5 gr | NOVARTIS PHARMA SCHWEIZ AG | E | N | 17/02/2020 |
51 | TOBRADEX | DEXAMETHASONE+ TOBRAMYCINE | 100 mg/300 mg | COLLYRE | FL/5 ml | NOVARTIS PHARMA SCHWEIZ AG | E | N | 17/02/2020 |
52 | DIPIPERON | PIPAMPERONE | 40 MG | COMP | B/20 | EUMEDICA PHARMACEUTICALS GmbH | E | N | Transfert 19/02/2020 |
53 | COSENTYX | SECUKINUMAB | 150MG/ML | SOL INJ | B/2 seringues pré_remplis | NOVARTIS EUROPHARM LIMITED IRLANDE | E | N | Transfert 21/02/2020 |
54 | COSENTYX | SECUKINUMAB | 150MG/ML | SOL INJ | B/2 Stylos pré_remplis | NOVARTIS EUROPHARM LIMITED IRLANDE | E | N | Transfert 21/02/2020 |
55 | ENBREL | ETANERCEPT | 50 mg | SOL INJ | B/4 stylos pré-remplis | PFIZER Europe MA EEIG | E | N | Transfert 21/02/2020 |
56 | ENBREL | ETANERCEPT | 25 mg | SOL INJ | B/4 seringues pré-remplis | PFIZER Europe MA EEIG | E | N | Transfert 21/02/2020 |
57 | STOCRIN | EFAVIRENZ | 30mg/ml | SOL BUVABLE | B/ 01 flacon de 180 ml | MSD PAYS BAS | V | N | 16/04/2020 |
58 | PROGESTAN | PROGESTERONE | 100 MG | CAPSULE MOLLE | B/30 | BESINS INTERNATIONAL | E | N | RE 07/05/2020 |
59 | PROGESTAN | PROGESTERONE | 200 MG | CAPSULE MOLLE | B/15 | BESINS INTERNATIONAL | E | N | RE 07/05/2020 |
60 | REFACTO AF | FACTEUR VIII | 1000 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
61 | REFACTO AF | FACTEUR VIII | 500 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
62 | REFACTO AF | FACTEUR VIII | 250 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
63 | FORXIGA | DAPAGLIFLOZINE | 5 MG | COMPRIME | B/28 | ASTRA ZENECA | E | N | RE du 08/05/2020 |
64 | FORXIGA | DAPAGLIFLOZINE | 10 MG | COMPRIME | B/28 | ASTRA ZENECA | E | N | RE du 08/05/2020 |
65 | JANUVIA | SITAGLIPTINE | 100 MG | COMPPRIME | B/28 | MSD PAYS BAS | E | N | TRANSFERT DU 08/05/2020 |
66 | REDEX | TADALAFIL | 5 MG | COMPRIME | B/28 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
67 | REDEX | TADALAFIL | 10MG | COMPRIME | B/2 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
68 | REDEX | TADALAFIL | 75MG | COMPRIME | B/2 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
69 | MERIONAL HG | GONODOTROPHINE MENOPAUSIQUE HUMAINE | 150 UI/ML | POUDRE P PREPARATION INJECTABLE | B/1FL+AP DE SOLVANT | IBSA BIOCHIMIQUE SA SUISSE | E | N | RE du 26/05/2020 |
70 | MERIONAL HG | GONODOTROPHINE MENOPAUSIQUE HUMAINE | 75 UI/ML | POUDRE P PREPARATION INJECTABLE | B/1FL+AP DE SOLVANT | IBSA BIOCHIMIQUE SA SUISSE | E | N | RE du 26/05/2020 |